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Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system. As an association between
MS and reduced cerebral venous blood drainage was hypothesised, our aim was to compare the size of the jugular
foramina in patients with MS and in control subjects.
Methods: Ethics committee approval was received for this retrospective case–control study. We collected imaging
and clinical data of 53 patients with MS (23 men, mean age 45 ± 9 years) and an age/gender-matched control
group of 53 patients without MS (23 men, mean age 46 ± 10 years). The minimal diameter of both jugular foramina
was measured on T1-weighted contrast-enhanced axial magnetic resonance images; the two diameters were
summed. Student t test and Spearman correlation coefficient were used for analysis. Reproducibility was estimated
using the Bland–Altman method.
Results: The mean diameter of the right foramen in patients with MS (6.3 ± 1.6 mm) was 10% smaller than that of the
controls (7.0 ± 1.4 mm) (p = 0.020); the mean diameter of the left foramen in patients with MS (5.6 ± 1.3 mm) was 7%
smaller than that of the controls (6.0 ± 1.3 mm) (p = 0.089). The sum of the diameters of both jugular foramina in
patients with MS (mean 11.9 ± 2.3 mm) was 8% smaller (p = 0.009) than that of the controls (mean 13.0 ± 2.1 mm). The
differences in diameters between patients with relapsing-remitting MS and patients with secondary progressive MS
were not significant (p≥ 0.332). There was no significant correlation between foramen diameters and the expanded
disability status scale (p≥ 0.079). Intra-reader and inter-reader reproducibility were 91% and 88%, respectively.
Conclusions: Jugular foramen diameter in patients with MS was 7-10% smaller than that in controls, regardless of the
MS disease course.
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expanded disability status scaleBackground
Multiple sclerosis (MS) is a chronic, autoimmune, inflam-
matory disease of the central nervous system characterised
by inflammation, demyelination, axonal loss, and eventual
neurodegeneration [1]. A number of pathophysiologic
mechanisms have been advocated and the unpredictabledistributed under the terms of the Creative Commons Attribution 4.0
/licenses/by/4.0/), which permits unrestricted use, distribution, and
ppropriate credit to the original author(s) and the source, provide a link to
nges were made.
Table 1 Clinical characteristics of patients with multiple sclerosis
Characteristic Value
Number of patients 53
Agea (years) 45 ± 9
Disease course (number of patients)
Relapsing–remitting 39
Secondary progressive 11
Primary progressive 2
Not defined 1
Age at diagnosisa (years)
Overall 33 ± 8
Relapsing–remitting 33 ± 8
Secondary progressive 34 ± 8
Primary progressive 33 and 49
Body mass indexa (kg/m2) 24 ± 4
Expanded disability status scale
Median 2.0
25th percentile 1.5
75th percentile 4.5
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the favourable effects of short-term treatments will be sus-
tained [2]. Despite previous research, the pathogenesis of
MS continues to challenge investigators.
Several studies have reported vascular abnormalities in
patients with MS. Imaging studies have also suggested de-
creased cerebral perfusion, affecting areas of white matter
that appears normal [3]. The main intracranial veins and
venous sinuses converge to form major dural sinuses, the
transverse sinus and the sigmoid sinus, which drain into
the extracranial veins through the jugular foramina. Jugular
foramina diameters typically range from 10 to 15 mm; the
right foramen is usually larger than the left one [4]. They
are composed of two parts: the pars nervosa, containing
the glossopharyngeal nerve and the inferior petrosal sinus,
and the pars vascularis, containing the internal jugular
vein, the vagal nerve, and the spinal accessory nerve.
In our clinical experience, we have noted cases of
small jugular foramina in patients with MS. Thus, the
aim of this study was to measure the venous portion of
the jugular foramina in a cohort of patients with MS and
to compare to control subjects.Minimum 1
Maximum 7
aMean ± standard deviationMethods
Study design and participants
This retrospective case–control study was approved by the
local ethics committee (Azienda Sanitaria Locale Milano 2,
Melegnano, Milan, Italy). We contacted a non-profit associ-
ation of patients with MS. This association provided us
with contrast-enhanced magnetic resonance imaging (MRI)
examinations of 53 patients with MS (23 men and 30
women, mean age 45 ± 9 years). Because these patients
have had multiple MRI studies at multiple centres, we ana-
lysed the most recent MRI examination. All patients signed
an informed consent and filled out a questionnaire request-
ing clinical data. In particular, information on the disease
course (relapsing–remitting, primary progressive, or sec-
ondary progressive) and the expanded disability status scale
(EDSS) were obtained. Patient characteristics are shown in
Table 1.
A control group matched for age and gender was set up
including a series of 53 consecutive outpatients without MS
(23 men and 30 women, mean age 46 ± 10 years) who were
referred to our institution for a contrast-enhanced MRI of
the brain. Indications in control subjects were as follows:
headache (n = 18), non-brain cancer staging (n = 5), dizzi-
ness (n = 5), hearing or visual disorders (n = 5), stroke (n =
5), primitive brain tumor (n = 4), infective diseases (n = 3),
epilepsy (n = 2), and other indications (n = 6).Measurements
To avoid bias, an independent reader created a database
pooling and randomizing the order of presentation ofpatients with MS and control subjects. This reader ex-
tracted from the full MRI examination only the axial
contrast-enhanced T1-weighted turbo spin-echo sequence.
Moreover, to avoid the identification of lesions in the white
matter, this reader selected only the slices containing the
jugular foramina, and verified the absence of lesions in
these slices. All images were anonymised and presented to
a second reader.
This second reader (who had 5 years of experience in
brain MRI) measured the size of both jugular foramina.
Considering the tortuosity of the foramen and its well-
defined vascular portion on contrast-enhanced images,
the reader measured the minimal lumen diameter of the
venous portion passing through the skull base (Fig. 1). To
estimate intra-reader and inter-reader reproducibility, this
reader repeated the measurements after 2 weeks in a sub-
set of 28 subjects randomly selected from the entire data-
base, whereas a third independent reader, who had 1 year
of experience, performed the measurement once for the
same 28 subjects.
All images were analysed using a remote workstation
(Leonardo, Siemens Medical Solutions, Erlangen, Germany)
and the Syngo-Argus software (v. VE32B, Siemens Medical
Solutions, Erlangen, Germany).
Statistical analysis
Continuous data were shown as mean ± standard devi-
ation or median and interquartile range, as appropriate.
Fig. 1 Magnification of a contrast-enhanced T1-weighted axial magnetic
resonance image showing the method used to measure the jugular
foramen diameter. Here the red caliper indicates the minimal diameter
of the right jugular foramen
Table 2 Comparison of the foramen diameter in patients with
multiple sclerosis and control subjects
Foramen diameter
Right Left Sum
Patients with multiple sclerosis
(mm)
6.3 ± 1.6 5.6 ± 1.3 11.9 ± 2.3
Controls (mm) 7.0 ± 1.4 6.0 ± 1.3 13.0 ± 2.1
p value* 0.020 0.089 0.009
Data are means ± standard deviation
*Student t test
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was performed. Accordingly, comparisons were per-
formed using the Student t test or the non-parametric
Mann–Whitney U test. In this regard, the EDSS was
considered an ordinal (non-continuous) variable.
Both the right and left foramina and the sum of their
diameters were analysed. The foramen diameter in pa-
tients with MS was compared to that in control subjects.
Similarly, a comparison was performed among patients
with different MS disease courses. Bivariate correlation
between the foramen diameter and the EDSS was esti-
mated by calculating the Spearman correlation coefficient.
Intra-reader and inter-reader reproducibility were esti-
mated using the Bland–Altman method. Considering the
differences between the compared data sets, we calcu-
lated the coefficient of repeatability as 2 × standard devi-
ation. Percent variability was calculated as the ratio of
the coefficient of repeatability to the grand mean. Fi-
nally, the complement to 100% of percent variability was
used as a measure of reproducibility [5]. Analyses were
performed using SPSS Statistics (SPSS inc. v.20, Chicago,
IL, USA). P-values <0.050 were considered statistically
significant.Results
Out of 53 patients with MS, 39 (73%) had relapsing–remit-
ting MS, 11 (21%) secondary progressive MS, 2 (4%) pri-
mary progressive MS, and 1 (2%) had a form of MS that
was not clinically defined. The distribution of all continu-
ous variables was normal (p ≥ 0.056), except for that of the
left foramen in patients with MS (p = 0.001). Age at diagno-
sis was 33 ± 8 years. The median EDSS was 2.0 (interquar-
tile range 1.5–4.5) (Table 1).
Data on the comparison of foramen diameter in patients
with MS and controls are shown in Table 2. In particular,
the mean diameter of the right foramen in MS patients
was 10% smaller than that in controls; the mean diameter
of the left foramen in MS patients was 7% smaller than
that in controls; the sum of the diameters in MS patients
was 8% smaller than that in controls.
Data on the comparison between patients with relaps-
ing–remitting MS and those with secondary progressive
MS are shown in Table 3. The difference in foramen diam-
eter was not significant (p ≥ 0.332). There was no signifi-
cant correlation between the left (r = −0.242, p = 0.143) or
right (r = −0.089, p = 0.595) foramen diameter and the
EDSS, though there was a borderline significant correl-
ation when the diameters of the right and left foramina
were summed (r = −0.288, p = 0.079).
Intra-reader and inter-reader reproducibility for the
measurement of foramen diameter was 91% and 88%, re-
spectively (Figs. 2 and 3).
Discussion
Anatomical variants of jugular and vertebral venous sys-
tems have not yet been systematically investigated and
classified. In recent years, several studies have reported
vascular abnormalities in patients with MS. Zamboni
and colleagues described an association between MS and
reduced venous blood drainage of the central nervous
system, a condition which is referred to as chronic cere-
brospinal venous insufficiency (CCSVI) [6]. Although
CCSVI has received attention in the MS community, the
impact of CCSVI on venous cerebral outflow circulation
and on the pathogenesis of MS has not been demon-
strated. Indeed, the prevalence of CCSVI in patients with
MS is highly debated, ranging from 0% to 100% [7–13].
Table 3 Comparison of the foramen diameter in patients with
multiple sclerosis in different courses of disease
Foramen diameter
Right Left Sum
Relapsing-remitting (mm) 6.5 ± 1.7 5.6 ± 1.4 12.1 ± 2.4
Secondary progressive (mm) 6.2 ± 1.5 5.2 ± 1.1 11.3 ± 2.2
p value* 0.577 0.332 0.344
Data represent mean ± standard deviation
*Student t test
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with smaller jugular foramina diameter compared to con-
trol subjects. These data agree with a previously reported
finding of an altered intracranial blood flow dynamics in
patients with MS [3]. However, we cannot speculate on a
causal relationship. On one hand, smaller jugular foramina
can act as a stenosis on the cerebral blood outflow, redu-
cing upstream cerebral perfusion; on the other hand, the
opposite may be true, i.e. reduced cerebral perfusion may
result in reduced downstream cerebral outflow with re-
duced jugular foramina size during cranial development.
Further studies are necessary to demonstrate the impact of
jugular foramina diameter on the overall cerebral blood
flow and its potential role in the pathogenesis of MS. A
small size of the jugular foramina could be an independent
finding associated to the disease.
The clinical relevance of this study may only be specu-
lated upon. Indeed, regardless of the actual relationship
between foramen diameter and reduced downstreamFig. 2 Bland–Altman graph showing intra-observer reproducibility for the m
observer reproducibility was 91%cerebral outflow, we may hypothesise that any endovascu-
lar venous angioplasty, as it is suggested for patients with
MS [6, 10], might in any case be useless in patients with
small jugular foramina. In fact, those treatments are typic-
ally performed in extracranial veins and a small jugular
foramen would act similarly to an upstream stenosis.
We found no significant differences between patients
with relapsing–remitting MS and those with secondary-
progressive MS in terms of diameters of the jugular foram-
ina, but this result may depend on the small sample size.
Of note, we could not investigate this in patients with pri-
mary progressive MS due to the very limited number of
those patients in our sample (two patients).
Similarly, there was no significant correlation between
jugular foramen diameter and the EDSS, though there
was a borderline significant negative correlation between
the sum of the two diameters and the EDSS. Even
though this correlation was only borderline significant, it
is in line with the primary result of this study. In fact, it
would suggest that the smaller the foramen diameters,
the higher the EDSS, i.e. the worst the clinical status of
the patients, which is a possibility to be confirmed by
larger studies.
Apart from the limited sample size, a limitation of our
study was that we measured the diameter of the venous
lumen of the jugular foramina, rather than the osseous
jugular foramina, which could probably be better evaluated
with computed tomography. However, patients with MS
are not followed up with cranial computed tomography,
which is less sensitive for identification of lesions in MSeasurement of the sum of diameters of both jugular foramina. Intra-
Fig. 3 Bland–Altman graph showing inter-observer reproducibility for the measurement of the sum of diameters of both jugular foramina.
Inter-observer reproducibility was 88%
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jugular vein is the functional structure deputed to blood
flow drainage and occupies the largest portion of the jugu-
lar foramen. In addition, the reproducibility of our mea-
surements was high even though the two readers had
different levels of experience in brain MRI. Finally, we did
not evaluate the impact on the results of confounders such
as body height or body mass index.
In conclusion, our preliminary study showed that the
diameter of the jugular foramina in patients with MS
was 7-10% smaller than in controls, regardless of the
clinical course of MS. Studies are warranted to confirm
and explore the clinical relevance of this finding.
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